ZMB Member Erich Gulbins
ZMB Member
Erich Gulbins
Next ZMB-Member
Prof. Dr. Erich Gulbins
Director of:
Department of Molecular BiologyUniversity Hospital Essen
Hufelandstraße 55
45122 Essen
- +49 201 723 3118
- Website
- Selected Publications
- Publication Metrics
-

- ZMB Research Program
Oncology
Research Overview
- Regulation and function of sphingolipids in bacterial infections, in particular pneumonia
1.1. Role of ceramide and sphingosine in cystic fibrosis
1.2. Molecular mechanisms of anti-bacterial effects of sphingosine
1.3. Development of novel treatments of pneumonia with Pseudomonas aeruginosa and Staphylococcus aureus
1.4. Regulation and function of sphingolipids in systemic infections with S. aureus and mycobacteria. - Sphingolipids in tumor therapy, with a focus on the regulation and function of sphingolipids in the immune system of the tumor host.
- Regulation and function of acid sphingomyelinase/ceramide in auto-immune disorders, in particular multiple sclerosis.
- The acid sphingomyelinase-ceramide-acid ceramidase axis as target of antidepressants. Role of this system in the pathogenesis and treatment of major depressive disorder.
- Targeting the mitochondrial Kv1.3 channel with novel specific inhibitors to treat cancer.
Selected Publications
-
Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophreniaIn: Molecular Psychiatry, Vol. 30, 2025, Nr. 7, pp. 2891 – 2906DOI (Open Access)
-
Selective inhibition of mitochondrial Kv1.3 prevents and alleviates multiple sclerosis in vivoIn: EMBO Molecular Medicine, 2025, in pressDOI (Open Access)
-
Immunotherapy targeting plasma ASM is protective in a mouse model of Alzheimer’s diseaseIn: Nature Communications, Vol. 14, 2023, Nr. 1, 1631DOI (Open Access)
-
Comorbid medical conditions are a key factor to understand the relationship between psychiatric disorders and COVID-19-related mortality : Results from 49,089 COVID-19 inpatientsIn: Molecular Psychiatry, Vol. 27, 2022, Nr. 3, pp. 1278 – 1280DOI (Open Access)
-
The acid sphingomyelinase/ceramide system in COVID-19In: Molecular Psychiatry, Vol. 27, 2022, Nr. 1, pp. 307 – 314DOI (Open Access)
-
Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defectsIn: Molecular Psychiatry, Vol. 26, 2021, Nr. 12, pp. 7403 – 7416DOI (Open Access)
-
Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19 : Current evidence and potential mechanismsIn: Molecular Psychiatry, Vol. 26, 2021, Nr. 12, pp. 7098 – 7099DOI (Open Access)
-
Acid ceramidase of macrophages traps herpes simplex virus in multivesicular bodies and protects from severe diseaseIn: Nature Communications, Vol. 11, 2020, Nr. 1, pp. 1338DOI, Online Full Text (Open Access)
-
Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial CellsIn: Cell Reports Medicine, Vol. 1, 2020, Nr. 8, 100142DOI (Open Access)
-
Antidepressants act by inducing autophagy controlled by sphingomyelin–ceramideIn: Molecular Psychiatry, Vol. 23, 2018, Nr. 12, pp. 2324 – 2346DOI (Open Access)
-
Antidepressants regulate autophagy by targeting acid sphingomyelinaseIn: Molecular Psychiatry, Vol. 23, 2018, Nr. 12, pp. 2251
-
Sphingolipids as targets for inhalation treatment of cystic fibrosisIn: Advanced Drug Delivery Reviews, Vol. 133, 2018, pp. 66 – 75
-
Acid Sphingomyelinase Inhibition in Stored Erythrocytes Reduces Transfusion-Associated Lung InflammationIn: Annals of Surgery, Vol. 265, 2017, Nr. 1, pp. 218 – 226DOI, Online Full Text (Open Access)
-
Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivoIn: Cancer Cell, Vol. 31, 2017, Nr. 4, pp. 516 – 531.e10DOI (Open Access)
-
Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial functionIn: Nature Communications, Vol. 8, 2017, pp. 480DOI (Open Access)
-
Paradoxical antidepressant effects of alcohol are related to acid sphingomyelinase and its control of sphingolipid homeostasisIn: Acta Neuropathologica, Vol. 133, 2017, Nr. 3, pp. 463 – 483DOI (Open Access)
-
β1-Integrin Accumulates in Cystic Fibrosis Luminal Airway Epithelial Membranes and Decreases Sphingosine, Promoting Bacterial InfectionsIn: Cell Host & Microbe, Vol. 21, 2017, Nr. 6, pp. 707 – 718.e8DOI, Online Full Text (Open Access)
-
Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphateIn: Journal of Hepatology, Vol. 64, 2016, Nr. 1, pp. 60 – 68DOI, Online Full Text (Open Access)
-
Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in miceIn: Nature Biotechnology, Vol. 33, 2015, Nr. 1, pp. 81 – 88
-
Regulation of hematogenous tumor metastasis by acid sphingomyelinaseIn: EMBO Molecular Medicine, Vol. 7, 2015, Nr. 6, pp. 714 – 734DOI (Open Access)
-
Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosaIn: EMBO Molecular Medicine, Vol. 6, 2014, Nr. 9, pp. 1205 – 1214DOI (Open Access)
-
Acid sphingomyelinase-ceramide system mediates effects of antidepressant drugsIn: Nature Medicine, Vol. 19, 2013, Nr. 7, pp. 934 – 938
-
Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemiaIn: Leukemia, Vol. 27, 2013, Nr. 8, pp. 1782 – 1785
-
It takes a CAD to kill a tumor cell with a LMPIn: Cancer Cell, Vol. 24, 2013, Nr. 3, pp. 279 – 281DOI (Open Access)
-
Inhibitors of mitochondrial Kv1.3 channels induce Bax/Bak-independent death of cancer cellsIn: EMBO Molecular Medicine, Vol. 4, 2012, Nr. 7, pp. 577 – 593DOI (Open Access)
-
Kinase suppressor of Ras-1 protects against pulmonary Pseudomonas aeruginosa infectionsIn: Nature Medicine, Vol. 17, 2011, Nr. 3, pp. 341 – 346
-
Lipids control mucus production in cystic fibrosisIn: Nature Medicine, Vol. 16, 2010, Nr. 3, pp. 267 – 268
-
Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosisIn: Nature Medicine, Vol. 14, 2008, Nr. 4, pp. 382 – 391DOI (Open Access)
